FAQ FAQ on EdenRx
Rosemary Daly, D.O., DABPM Board-Certified Obesity Medicine Physician Medical Weight Loss & GLP-1 Care Board-Certified Physician Assistant Medical Weight Loss & Primary Care Board-Certified Family Nurse Practitioner Medical Weight Loss, Wellness & Peptide Therapy Last Updated: June 26, 2026 This page is reviewed periodically to reflect current clinical guidance, treatment options, and patient care standards
Scientists are racing to discover whether the new class of weight-loss drugs, originally approved to treat type 2 diabetes, might be repurposed to treat all kinds of other conditions
Weight-bearing exercises, like walking or resistance training, support bone health and reduce the risk of fractures
Studies suggest bioavailability around 2030%
In the study which its worth noting was sponsored by Ozempic and Wegovy manufacturer Novo Nordisk 400 patients on five continents were given weekly injections of either a placebo or semaglutide